Morgan Stanley’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $184K | Buy |
24,693
+17,716
| +254% | +$132K | ﹤0.01% | 5887 |
|
|
2025
Q1 | $68.2K | Buy |
6,977
+4,658
| +201% | +$45.5K | ﹤0.01% | 6167 |
|
|
2024
Q4 | $12.5K | Sell |
2,319
-29
| -1% | -$157 | ﹤0.01% | 6725 |
|
|
2024
Q3 | $14.8K | Sell |
2,348
-7,850
| -77% | -$49.4K | ﹤0.01% | 6601 |
|
|
2024
Q2 | $64.6K | Sell |
10,198
-30,993
| -75% | -$196K | ﹤0.01% | 6099 |
|
|
2024
Q1 | $338K | Sell |
41,191
-4,639
| -10% | -$38K | ﹤0.01% | 5506 |
|
|
2023
Q4 | $382K | Buy |
45,830
+42,351
| +1,217% | +$353K | ﹤0.01% | 5720 |
|
|
2023
Q3 | $44.8K | Sell |
3,479
-1,624
| -32% | -$20.9K | ﹤0.01% | 6210 |
|
|
2023
Q2 | $81.5K | Buy |
5,103
+1,988
| +64% | +$31.7K | ﹤0.01% | 6034 |
|
|
2023
Q1 | $40.8K | Buy |
3,115
+2,814
| +935% | +$36.9K | ﹤0.01% | 6354 |
|
|
2022
Q4 | $2.26K | Buy |
301
+100
| +50% | +$750 | ﹤0.01% | 7341 |
|
|
2022
Q3 | $1K | Buy |
201
+1
| +0.5% | +$5 | ﹤0.01% | 7584 |
|
|
2022
Q2 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 7601 |
|